Literature DB >> 27829744

Bone morphogenetic proteins: Signaling periodontal bone regeneration and repair.

G Sai Anusuya1, M Kandasamy2, S A Jacob Raja1, S Sabarinathan3, P Ravishankar4, Balu Kandhasamy5.   

Abstract

Bone morphogenetic proteins (BMPs) are a group of growth factors also known as cytokines and as metabologens. Originally discovered by their ability to induce the formation of bone and cartilage, BMPs are now considered to constitute a group of pivotal morphogenetic signals, orchestrating tissue architecture throughout the body. The important functioning of BMP signals in physiology is emphasized by the multitude of roles for dysregulated BMP signaling in pathological processes. A study done wherein it was found that protein extracts from bone implanted into the animals at nonbone sites induced the formation of new cartilage and bone tissue. This protein extract contained multiple factors that stimulated bone formation and was termed as "BMP." There are at least 15 different BMPs identified to date and are a part of the transforming growth factor-β super family. The most widely studied BMPs are BMP-2, BMP-3 (osteogenin), BMP-4, and BMP-7 (osteogenic protein-1). Now, any recombination type of morphogenic proteins have been synthesized, for example - recombinant human BMPs.

Entities:  

Keywords:  Bone morphogenetic proteins; cytokines; growth factor; periodontal regeneration

Year:  2016        PMID: 27829744      PMCID: PMC5074037          DOI: 10.4103/0975-7406.191964

Source DB:  PubMed          Journal:  J Pharm Bioallied Sci        ISSN: 0975-7406


Periodontal disease activity results in the destruction of periodontal tissues namely, periodontal ligament, alveolar bone and cementum, eventually leading to tooth loss if left untreated.[1] Periodontal therapy can be undertaken by nonsurgical and by surgical methods. Periodontal therapeutic procedures are directed to arrest disease progression and achieve regeneration of lost tissues. Periodontal surgical procedures are carried out as a treatment modality to arrest the disease progression. The tissue levels are not changed to the predisease condition. The periodontal ligament being a very complicated one involves various components for regression. All the components must be restored to their original position, for that the cells have to repopulate the wound created after surgery and create an appropriate matrix and later differentiate to form the respective tissues. At many occasions, procedures such as bone grafting, use of membrane are undertaken to achieve regeneration. The latest among the regenerative procedures is the use of growth factors. Growth factors include a group of polypeptides and are involved in a variety of cell-to-cell and cell-matrix interactions both during the development of a particular organ, during normal health state, and also most important, i.e., during wound healing.[2] These growth factors mediate cellular processes such as – DNA synthesis, mitosis, chemosis, and also conversion of cells in the resting phase of the cell cycle into replicating cells. Various growth factors have been isolated and studied, namely, platelet-derived growth factor, fibroblast growth factors, insulin-like growth factor, transforming growth factors, bone morphogenetic proteins (BMPs) with cementum derived growth factors and periodontal ligament derived growth factors. For a growth factor to affect periodontal regeneration, it must be able to stimulate the formation of both mineralized and nonmineralized tissues. The studies have shown that there has been periodontal regeneration with the use of growth factors alone or in combination. The effects of platelet-derived, insulin-like transforming and fibroblast growth factors, and BMPs in periodontal regeneration have been studied. The studies have promised a bright future for the use of these in the field of periodontal regeneration. The goal of periodontal therapy is to provide a dentition that functions in health and comfort for the life of the patient.

Discovery of Growth Factors

Growth factors were first described in the 1960's when substances such as blood fluids (e.g., fetal calf serum) and tissue extracts were added to cells in tissue culture.[134] They usually involve in cell stimulation and proliferation, differentiation or migration, for example, nerve growth factor, which caused growth of neurons in chick embryos. The study of growth factors is still largely a tissue culture-based (in vitro) science. Since the growth factors occur in such small amounts, it was difficult to isolate and identify them, until sophisticated biochemical methods were developed. Subsequently, these substances were identified and purified as peptides.[56] Growth factors are such as hormones regulate cell activity. There are currently about 130 established and characterized growth factors. Some of these factors are associated with the immune system.[4]

Bone Morphogenetic Proteins

A study done, wherein it was found that protein extracts from bone implanted into the animals at nonbone sites induced the formation of new cartilage and bone tissue.[789101112] This protein extract contained multiple factors that stimulated bone formation and was termed as “BMP.” There are at least 15 different BMPs identified to date and are a part of the transforming growth factor-β superfamily. The most widely studied BMPs are BMP-2, BMP-3 (osteogenin), BMP-4, and BMP-7 (osteogenic protein-1). Now, any recombination type of morphogenic proteins has been synthesized, for example - recombinant human BMPs (rh-BMP). The BMPs show sequence homologies with transforming growth factor-β. It is found that BMPs are related to regulatory genes.[1314151617181920] The other factors that have homologies with BMPs are activins, inhibins, and mullerian inhibiting substances involved in follicle stimulating hormone release and ductal development. Originally, seven such proteins were discovered. Of these, six (BMP2 through BMP7) belong to the transforming growth factor beta superfamily of proteins. BMP1 is a metalloprotease. Since then, thirteen more BMPs have been discovered, bringing the total to twenty.

Effects

Stimulate bone and cartilage formation (BMP-2) Initiate endochondral bone formation (BMP-3, BMP-7) The high level of BMPs probably indicates an endocrine-like action Role in development of the central nervous system (BMP-3) BMP-2 and BMP-4 in RNA transcripts are found to have a role in developing tooth buds, odontoblast layer, and other craniofacial structures BMPs are found to help growth of hematopoietic cells and epithelial differentiation It is involved in extracellular matrix during repair and regeneration It is also found to stimulate angiogenesis by extracellular matrix interactions Binds to type IV collagen.

Conclusion

BMP represents a set of unique factor that induces new bone formation at the site of implantation instead of changing the growth rate of preexisting bone.[21] rh-BMP-2, for example, has shown to induce ectopic bone formation in an in vivo setting. Cell culture studies indicate that rh BMP-2 can cause mesenchymal precursor cells to differentiate into cartilage and bone forming cells. Additional animal studies have shown that rh-BMP-2 is capable of replacing large defects about 2.5 mm deep in canine mandibles healing a variety of long bone defects in orthopedic models and concluded that these BMPs can be used for a variety of periodontal conditions.[1222232425262728]

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  26 in total

Review 1.  Bone morphogenetic proteins: background and implications for oral reconstruction. A review.

Authors:  M B Lee
Journal:  J Clin Periodontol       Date:  1997-06       Impact factor: 8.728

2.  De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation.

Authors:  Philip J Boyne; Leslie C Lilly; Robert E Marx; Peter K Moy; Myron Nevins; Daniel B Spagnoli; R Gilbert Triplett
Journal:  J Oral Maxillofac Surg       Date:  2005-12       Impact factor: 1.895

Review 3.  Biologic modifiers in periodontal regeneration.

Authors:  L K McCauley; M J Somerman
Journal:  Dent Clin North Am       Date:  1998-04

4.  Ability of commercial demineralized freeze-dried bone allograft to induce new bone formation is dependent on donor age but not gender.

Authors:  Z Schwartz; A Somers; J T Mellonig; D L Carnes; D D Dean; D L Cochran; B D Boyan
Journal:  J Periodontol       Date:  1998-04       Impact factor: 6.993

5.  Bone: formation by autoinduction.

Authors:  M R Urist
Journal:  Science       Date:  1965-11-12       Impact factor: 47.728

6.  Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation.

Authors:  Joseph P Fiorellini; T Howard Howell; David Cochran; Jay Malmquist; Leslie C Lilly; Daniel Spagnoli; Joseph Toljanic; Archie Jones; Myron Nevins
Journal:  J Periodontol       Date:  2005-04       Impact factor: 6.993

7.  Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation.

Authors:  T K Sampath; A H Reddi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

Review 8.  Bone morphogenetic proteins (BMPs): how do they function and what can they offer the clinician?

Authors:  Nikitas Sykaras; Lynne A Opperman
Journal:  J Oral Sci       Date:  2003-06       Impact factor: 1.556

9.  Bone morphogenetic protein induces bone in the squirrel monkey, but bone matrix does not.

Authors:  P Aspenberg; E Wang; K G Thorngren
Journal:  Acta Orthop Scand       Date:  1992-12

10.  Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells.

Authors:  R S Thies; M Bauduy; B A Ashton; L Kurtzberg; J M Wozney; V Rosen
Journal:  Endocrinology       Date:  1992-03       Impact factor: 4.736

View more
  3 in total

1.  Local supplementation with plant-derived recombinant human FGF2 protein enhances bone formation in critical-sized calvarial defects.

Authors:  Sher Bahadur Poudel; Chang-Ki Min; Jeong-Hoon Lee; Yun-Ji Shin; Tae-Ho Kwon; Young-Mi Jeon; Jeong-Chae Lee
Journal:  J Bone Miner Metab       Date:  2019-03-06       Impact factor: 2.626

2.  Bone morphogenetic protein 4 rescues the bone regenerative potential of old muscle-derived stem cells via regulation of cell cycle inhibitors.

Authors:  Haizi Cheng; Xueqin Gao; Matthieu Huard; Aiping Lu; Joseph J Ruzbarsky; Sara Amra; Bing Wang; Johnny Huard
Journal:  Stem Cell Res Ther       Date:  2022-07-30       Impact factor: 8.079

3.  Recent advances in periodontal regeneration: A biomaterial perspective.

Authors:  Yongxi Liang; Xianghong Luan; Xiaohua Liu
Journal:  Bioact Mater       Date:  2020-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.